Clinical trials
Muscular Atrophy trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McMaster University | 6 |
| McGill University | 3 |
| Concordia University, Montreal | 2 |
| Queen's University | 2 |
| University of Saskatchewan | 2 |
| Amazentis SA | 1 |
| Dr. Chris McGlory, PhD | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| University of Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 19 |
| Muscular Disorders, Atrophic | 4 |
| Sarcopenia | 3 |
| Insulin Resistance | 2 |
| Low Back Pain | 2 |
| Atrophy | 1 |
| Frailty | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
| Nervous System Diseases | 1 |
| Neurologic Manifestations | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.